Phreesia (NYSE:PHR) Reaches New 12-Month Low – Here’s What Happened

Shares of Phreesia, Inc. (NYSE:PHR) hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $11.28 and last traded at $11.67, with a volume of 189946 shares trading hands. The stock had previously closed at $12.06.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the stock. Truist Financial set a $24.00 target price on shares of Phreesia in a research report on Thursday, January 8th. Wall Street Zen cut shares of Phreesia from a “strong-buy” rating to a “buy” rating in a report on Sunday, February 8th. Canaccord Genuity Group decreased their price target on Phreesia from $38.00 to $33.00 and set a “buy” rating for the company in a report on Tuesday, December 9th. Royal Bank Of Canada started coverage on Phreesia in a research report on Friday, January 9th. They set a “moderate buy” rating and a $26.00 target price on the stock. Finally, DA Davidson dropped their price target on shares of Phreesia from $35.00 to $30.00 and set a “buy” rating on the stock in a research note on Friday, January 23rd. Seventeen investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $29.12.

Phreesia Trading Down 2.0%

The company has a fifty day simple moving average of $14.14 and a 200-day simple moving average of $19.61. The company has a market capitalization of $712.87 million, a PE ratio of -118.34 and a beta of 0.67. The company has a current ratio of 2.44, a quick ratio of 2.44 and a debt-to-equity ratio of 0.01.

Phreesia (NYSE:PHR) last released its quarterly earnings data on Monday, December 8th. The company reported $0.10 EPS for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.11. The firm had revenue of $120.33 million for the quarter, compared to analysts’ expectations of $119.98 million. Phreesia had a negative return on equity of 1.31% and a negative net margin of 1.16%.The firm’s quarterly revenue was up 12.7% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.25) earnings per share. Analysts predict that Phreesia, Inc. will post -1.1 EPS for the current year.

Insider Activity at Phreesia

In other Phreesia news, SVP Amy Beth Vanduyn sold 2,602 shares of the firm’s stock in a transaction that occurred on Thursday, January 8th. The shares were sold at an average price of $17.01, for a total value of $44,260.02. Following the completion of the transaction, the senior vice president owned 160,238 shares of the company’s stock, valued at $2,725,648.38. This trade represents a 1.60% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Evan Roberts sold 6,317 shares of the company’s stock in a transaction that occurred on Thursday, January 8th. The stock was sold at an average price of $17.01, for a total transaction of $107,452.17. Following the sale, the insider owned 834,632 shares in the company, valued at $14,197,090.32. The trade was a 0.75% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 60,766 shares of company stock worth $1,013,817 over the last ninety days. Company insiders own 5.50% of the company’s stock.

Hedge Funds Weigh In On Phreesia

A number of hedge funds and other institutional investors have recently made changes to their positions in PHR. Federated Hermes Inc. purchased a new stake in shares of Phreesia during the 3rd quarter worth approximately $32,000. Van ECK Associates Corp grew its holdings in shares of Phreesia by 78.7% during the 4th quarter. Van ECK Associates Corp now owns 2,502 shares of the company’s stock worth $42,000 after purchasing an additional 1,102 shares during the period. Asset Management One Co. Ltd. purchased a new stake in shares of Phreesia during the 3rd quarter worth about $45,000. KBC Group NV raised its position in Phreesia by 83.4% in the fourth quarter. KBC Group NV now owns 3,449 shares of the company’s stock valued at $58,000 after purchasing an additional 1,568 shares during the period. Finally, Garner Asset Management Corp acquired a new stake in Phreesia in the fourth quarter valued at approximately $81,000. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.